GHK-Cu (100 mg Vial)
Dosing & reconstitution protocol
Quick Reference
Overview
GHK-Cu 100 mg vial reconstituted with 3.0 mL for ~33.3 mg/mL concentration. For ≤10-unit administrations, consider 30- or 50-unit insulin syringes for improved readability. At this concentration, a single vial provides enough for 8–12 weeks of daily use.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–4 | 1.0 mg | 3 units | 0.03 mL |
| Weeks 5–8 | 1.5 mg | 4.5 units | 0.045 mL |
| Weeks 9–12 | 2.0 mg | 6 units | 0.06 mL |
Reconstitution Instructions
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C, protected from light; use within 30 days.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓Peptide Vials (GHK-Cu, 100 mg): 1 vial (~50 mg total)
- ✓Insulin Syringes (U-100, 30 or 50-unit preferred): 40 syringes (5/day, 5 days)
- ✓Bacteriostatic Water (10 mL): 1 bottle (3 mL needed)
- ✓Alcohol Swabs: 1 × 100-count box (80 swabs)
Dosing Protocol
Schedule
Inject once daily subcutaneously, 5 days per week (Mon–Fri) with weekends off.
Cycle Structure
8–12 weeks typical. Benefits are cumulative. Follow with a 2–4 week break.
Storage & Handling
- ✓Lyophilized: Store at −20 °C or lower in dry, dark conditions.
- ✓Reconstituted: Refrigerate at 2–8 °C; use within 30 days.
- ✓Faint blue tint after reconstitution is normal (copper complex).
- ✓Allow vials to reach room temperature before opening.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Use 30- or 50-unit insulin syringes for small volumes (≤0.10 mL) for better accuracy.
- ✓Rotate injection sites to prevent irritation and lipodystrophy.
- ✓Pairs well with MOTS-c in longevity-focused research protocols.